Abstract
Novel halohydrin and oxime derivatives of radicicol (1) were prepared and evaluated for their v-src tyrosine kinase inhibitory, antiproliferative, and antitumor activities. Some of the resulting derivatives showed significantly improved antitumor activities than those of 1 in vitro as tested in a cell proliferation assay and in vivo using sc-inoculated human breast carcinoma and epidermoid tumor models. Design and synthesis of radicicol-based novel affinity probes are also described.
MeSH terms
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / pharmacokinetics
-
Antineoplastic Agents / pharmacology*
-
Breast Neoplasms / drug therapy
-
Breast Neoplasms / pathology
-
Carcinoma, Squamous Cell / drug therapy
-
Carcinoma, Squamous Cell / pathology
-
Chromatography, High Pressure Liquid
-
Drug Screening Assays, Antitumor
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / pharmacology
-
Female
-
Humans
-
Indicators and Reagents
-
Lactones / chemical synthesis*
-
Lactones / pharmacokinetics
-
Lactones / pharmacology*
-
Macrolides
-
Oximes / chemical synthesis*
-
Oximes / pharmacology*
-
Structure-Activity Relationship
-
Tumor Cells, Cultured
-
src-Family Kinases / antagonists & inhibitors
Substances
-
Antineoplastic Agents
-
Enzyme Inhibitors
-
Indicators and Reagents
-
Lactones
-
Macrolides
-
Oximes
-
src-Family Kinases
-
monorden